TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Seroconversion rate of hemagglutination inhibition (HI) antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to Treatment Withdrawal
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Trauma-Related Nightmare Survey (TRNS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Objective Response Rate (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gingival Recession (Root Coverage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic accuracy of trichoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC[0-inf]) of DTG and RPV in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time 0 to the last measurable timepoint (AUC[0-t]) of DTG and RPV in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal drug concentration (Cmax) of DTG and RPV in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of Advance Directive
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in tumor FDG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of children with inherited cardiac disorders respecting guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Geometric Mean Concentrations (GMCs) of Binding Antibody Levels Against Ebola Virus Glycoprotein (EBOV GP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to relapse of anxious symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of BCI Usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the MATRICS Consensus Cognitive Battery (MCCB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in VO2Max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroid-symptom questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wechsler Memory Scale-Version IV (WMS-IV)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Wound Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Weight Change Per Week From Baseline to Termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Body Mass Index (BMI) Change Per Week From Baseline to Termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Serum Insulin Level Change Per Week From Baseline to Termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Reported Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: progression of macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: DLTs/Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Device derived adherence to structured exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device derived duration to structured exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device derived intensity of structured exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain perceived at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain perceived at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-Free Survival at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Volume retrieval efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of osteoporotic PFF risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants With Partial Response (PR) of Target Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual Task Effect on Arm and Foot Tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phonetic analysis of dysarthria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in E to E' velocity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Outcomes of variceal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: % of bleeds reported to the HTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % of recommended therapy recorded in bleeding logs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Buprenorphine Treatment Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type and incidence of DLT
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of treatment related AE
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of CRS and Neurotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in office-based systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Degree of dissociative tendencies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Insulin Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline Body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Successful Assessment of Lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Health-related Quality of Life: VR-6 Physical Health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient Health-related Quality of Life: VR-6 Mental Health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient Satisfaction With Care: ACES
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood DNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: fentanyl consumption for IV-PCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF-alpha blood level change from time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-1beta blood level change from time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-6 Blood Level change from time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hsCRP Blood Level change from time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CBC Panel change from time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESR blood test change from time 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Recession Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 days prolonged abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency and intensity of hormone withdrawal associated symptoms (headache and pelvic pain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating tumor cells (CTCs) for non-invasive monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Extracellular vesicles (EVs) for non-invasive monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Urine as a source of GBM-specific nucleic acids fragments for disease monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: growth-velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Reported Outcomes Measurement (PROMIS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-Reported Outcome Measure (SF12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital Anxiety and Depression Scale (HADS) anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Telomere length of circulating leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analysis of f-waves on ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean intraoperative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: No headache pain at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of most bothersome migraine-associated symptom at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral oxygen saturation (rSO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: levels of homocysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2 and 5 year-disease free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Stools consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Utilization of priority maternal and child health services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of oral panobinostat
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of oral panobinostat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superior vena cava (SVC) flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraventricular hemorrhage (IVH) assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Anterior cerebral artery (ACA) flow velocity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cochin hand functional scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Subjective Visual Vertical Test (SVV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Postural Vertical Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specific gravity of urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osmolality (Urine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osmolality (Blood)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vasopressin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sodium (blood)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Second-phase insulin response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: First variceal bleeding within 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline Modified Fatigue Impact Scale at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline Multidimensional Assessment of Fatigue at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Foot Health Status Questioner (FHSQ) PAIN
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Effectiveness of the RheumaLive Application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Serious Adverse Events (MSAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of good quality embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCτ of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Css,max of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire for Patients to Want to Use Guided Imagery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Amount of Patients Who Find Using Guided Imagery Beneficial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of intervention sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quantification of specific cytokines of the Th17 immune response (IL-17 A and IL-23) in the serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quantification of LTh17 by flow cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Measurement of the activation level of genes specifically involved in Th17 response using RT-PCR on frozen mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of LEO 43204
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of LEO 43204
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gas Trapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Presence of donor-derived DNA in semen samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total narcotic dose in milligram morphine equivalents (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment-hand & wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of non-union after tibia fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional Recovery after Achilles Tendon Rupture
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Toilet Usability Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood Pressure Control (BP < 140/90 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: aEEG score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adherence of occupational therapists to the COTiD program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Community occupational therapy use according to the COTiD program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Costs of the implementation strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Benefit of 7T MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events related to 64Cu-SARTATE
Endpoint domain: Adverse events/effects
Primary endpoint: Time-to-first event of the composite endpoint
Endpoint domain: Mortality/survival
Primary endpoint: mitochondrial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bladder sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Response of primary tumor and metastases to everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of workplace violence
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical intensive care unit length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hand Function Assessed With the Jebsen Taylor Hand Function Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Glucose Area Under the Concentration Curve Zero Through 5 Hours (AUC 0-5h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in microbiota diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microbiota taxonomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microbiota resistome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hepatic insulin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Muscle Activity Onset Delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Microcirculatory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue Index From the Isokinetic Fatigue Test
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Expired CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PANSS Positive and Negative Symptom Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee extensor isometric performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee extensor isokinetic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to all-cause death or first occurrence of hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Atrial natriuretic peptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain TSPO occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Free-living gait stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior Knee Pain Scale (AKPS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in ATPmax (Maximal ATP Synthetic Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lymphatic function or dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the thoracic kyphosis angle (°)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the thoracic flexion and extension range of motion (degree)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the Overall Stability Indices for the Fall Risk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Recurrence of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of GMPR protein in isolated erythrocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Levels of SWAP70 protein in immune cell subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of immunoglobulin isotypes in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: [18F]FES uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Measurement of extra-alveolar diameter of capillaries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Measurement of intercapillary distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Measurement of length of the capillary portions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnostic performance of PET/MR imaging metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal foveal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quinnell trigger finger grading system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous Performance Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Activities of Daily Living (ADL) & Instrumental Activities of Daily Living (IADL) scales
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: World Health Organization Quality of Life - HIV Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of biopsies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Sweet Taste Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pleasantness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients accurately diagnosed with retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Expression of melanoma-associated antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes